Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
NCT01150487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288
Last updated 2025-12-23
Summary
The aim of this study is to determine a comprehensive immune profile of transplant donors and recipients through assessment of immune cell compositions in bone marrow, and lymph nodes.
Conditions
- Transplantation, Kidney
- Living Donors
- Kidney Transplant Recipients
Interventions
- PROCEDURE
-
bone marrow aspirations
A bone marrow aspiration from each hip bone of the patients.
- PROCEDURE
-
lymph node collection
An Iliac lymph node collection.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH - lead OTHER
Principal Investigators
-
Mark Stegall, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-05
- Primary Completion
- 2025-12-15
- Completion
- 2025-12-15
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome
NCT03298698 ·Status: UNKNOWN ·Phase: PHASE3
-
Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores
NCT01496417 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
NCT00609544 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nefecon and Ambrisentan in IgA Nephropathy
NCT07030894 ·Status: RECRUITING ·Phase: PHASE4
-
Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease
NCT01156428 ·Status: COMPLETED
-
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
NCT04629248 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
NCT04950114 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Patients With Idiopathic Membranous Nephropathy
NCT00135954 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
NCT05532111 ·Status: UNKNOWN ·Phase: NA
-
A Study of LY3819469 in Participants With Impaired and Normal Renal Function
NCT05841277 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure
NCT00511407 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
NCT07165015 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
NCT02282930 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
NCT00120263 ·Status: COMPLETED ·Phase: NA
-
Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
NCT02511418 ·Status: COMPLETED ·Phase: NA
-
The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
NCT06889948 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation
NCT03373461 ·Status: COMPLETED ·Phase: PHASE2
-
FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation
NCT05246618 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
NCT04776187 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
NCT05429515 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function
NCT06698549 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation
NCT01279538 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
NCT01135316 ·Status: COMPLETED
-
Mycophenolate Mofetil in Membranous Nephropathy
NCT00135967 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
NCT02586051 ·Status: COMPLETED ·Phase: PHASE1